Loading...
Market
Which former Pfizer executive will be appointed to assist with strategic changes by March 31, 2025?
2
Resolution / Starting Odds
Executive A • 25%
Executive B • 25%
Both • 25%
Neither • 25%
Official announcements from Pfizer or credible news sources
Story
Starboard Value Takes $1 Billion Stake in Pfizer, Pushes for Strategic Changes
Oct 7, 2024, 12:36 AM
Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer, aiming to push the struggling drugmaker to improve its performance. According to sources, Starboard has approached two former Pfizer executives to assist in this effort. The Wall Street Journal reported on Sunday night that Pfizer's shares have been under pressure, particularly after the company overestimated future demand for its pandemic-related products. Pfizer's market cap is approximately $160 billion, making Starboard's stake a small but potentially influential percentage. The company is expected to have a board meeting later this week. Starboard is pushing for strategic changes to enhance Pfizer's performance.
View original story
Similar markets
Internal candidate • 25%
External candidate from a major pharmaceutical company • 25%
External candidate from a biotech startup • 25%
Other • 25%
Boehringer Ingelheim • 25%
AstraZeneca • 25%
Another major pharmaceutical company • 25%
A biotech startup • 25%
Albert Bourla • 25%
Current Pfizer executive • 25%
External candidate • 25%
Other • 25%
Opposition • 25%
Support • 25%
Neutral • 25%
No official statement • 25%
Increased R&D investment • 25%
New product launches • 25%
Cost-cutting measures • 25%
Other strategic changes • 25%
Current CFO • 25%
Newly hired compliance officer • 25%
Current COO • 25%
Other • 25%
Major acquisition • 25%
Divestiture of a major division • 25%
Significant R&D pivot • 25%
No major changes • 25%
CEO replaced • 25%
CFO replaced • 25%
Both CEO and CFO replaced • 25%
No changes in executive leadership • 25%